alexa Shhyam Moorthy | University of Texas

Cancer Medicine & Anti Cancer Drugs
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Shhyam Moorthy

Shhyam Moorthy Shhyam Moorthy Clinical Researcher University of Texas M.D.Anderson Cancer Center, Houston, Texas 

Dr Shhyam Moorthy has done his Doctorate (Ph.D.) in Cancer Biology from the University of Texas M.D. Anderson Cancer Center (ranked number 1 in “Best Hospitals for Cancer”, U.S. News and World reports), he had over 8 years’ experience in pre-clinical research including 3 years of undergraduate honors research, 5 years of graduate research work and 1.5 years of clinical research.He is currently working at the largest Phase 1 clinical trials group at M.D. Anderson to effectively translate pre-clinical research into targeted therapeutics

Research Interest

Cancer Biology; BOIN and modified-Fibonacci dose escalation; immunotherapy; targeted therapy; drug-related toxicities; RECIST evaluation for tumor progression

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version